ISM
Immunology·MeSH: Hypersensitivity
143 drugs in development·73 companies·1 clinical trial
Drug Pipeline by Phase
Approved(53)
Phase 3(14)
Phase 2(38)
Phase 1(18)
Preclinical(8)
Unknown(1)
| Drug | Company |
|---|---|
| Synthroid™ | ABBOTT LABORATORIES (ABT) |
Phase 2/Phase 3(1)
| Drug | Company |
|---|---|
| tecarfarin | Cadrenal Therapeutics, Inc. (CVKD) |
Phase 4(10)
Compare drugs
Frequently asked questions
How many drugs are in development for ISM?
BioSniper tracks 143 drugs in development for ISM across 73 companies.
How many clinical trials target ISM?
There are 1 clinical trial targeting ISM tracked by BioSniper.
Deep-dive into ISM
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis